Inventor · disambiguated record
Hailin Zheng
Also filed as: ZHENG HAILIN
27 granted patents·15 pending applications·354 citations·filing 2003–2025
96Inventor score
Top patents by PatentIndex Score
42 records- 0198US11773095B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2022·Granted Oct 3, 2023·9 cites·21 claims
- 0298US11427587B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2018·Granted Aug 30, 2022·31 cites·13 claims
- 0398US8664207B2Organic compoundsLI PENG·Filed 2009·Granted Mar 4, 2014·99 cites·31 claims
- 0497US9073936B2Organic compoundsLI PENG·Filed 2014·Granted Jul 7, 2015·38 cites·22 claims
- 0594US12173004B2Pharmaceutical compositions comprising heterocycle fused gamma carboline prodrugsINTRA CELLULAR THERAPIES INC·Filed 2023·Granted Dec 24, 2024·1 cites·24 claims
- 0694US9556186B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2015·Granted Jan 31, 2017·14 cites·27 claims
- 0794US9546175B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2015·Granted Jan 17, 2017·8 cites·16 claims
- 0894US8927556B21H-pyrrolo[3,4-D]pyrimidin-2(6H)-one compoundsLI PENG·Filed 2009·Granted Jan 6, 2015·27 cites·19 claims
- 0994US8859564B2Pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione derivatives useful as inhibitors of phosphodiesterase 1LI PENG·Filed 2009·Granted Oct 14, 2014·28 cites·23 claims
- 1094US8858911B2Phosphodiesterase 1-targeting tracers and methodsLI PENG·Filed 2010·Granted Oct 14, 2014·23 cites·6 claims
- 1194US8846693B2Optionally substituted pyrazolo[3,4-d]pyrimidine-4,6-dionesLI PENG·Filed 2008·Granted Sep 30, 2014·29 cites·20 claims
- 1293US9598426B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2014·Granted Mar 21, 2017·15 cites·16 claims
- 1388US9487527B2Pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione derivatives useful as inhibitors of phosphodiesterase ILI PENG·Filed 2014·Granted Nov 8, 2016·10 cites·6 claims
- 1486US10150774B2Compounds and methodsINTRA CELLULAR THERAPIES INC·Filed 2015·Granted Dec 11, 2018·5 cites·28 claims
- 1584US12331052B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Jun 17, 2025·1 cites·34 claims
- 1679US9556185B2Organic compoundsLI PENG·Filed 2011·Granted Jan 31, 2017·4 cites·8 claims
- 1778US10105349B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2015·Granted Oct 23, 2018·2 cites·5 claims
- 1876US10561656B2Organic compoundsLI PENG·Filed 2012·Granted Feb 18, 2020·2 cites·5 claims
- 1970US10300064B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2015·Granted May 28, 2019·1 cites·8 claims
- 2070US8685955B2Neuroprotective iron chelators and pharmaceutical compositions comprising themYOUDIM MOUSSA B H·Filed 2011·Granted Apr 1, 2014·2 cites·9 claims
- 2169US10131671B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2015·Granted Nov 20, 2018·1 cites·38 claims
- 2269US2025388581A1Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2025·Application pending·0 cites
- 2363US2015038474A1Organic compoundsLI PENG·Filed 2014·Application pending·0 cites
- 2461US8058442B2Neuroprotective iron chelators and pharmaceutical compositions comprising themYOUDIM MOUSSA·Filed 2003·Granted Nov 15, 2011·4 cites·35 claims
- 2560US2014005155A1Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2013·Application pending·0 cites
- 2659US2015072965A1Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2014·Application pending·0 cites
- 2758US2015080357A1Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2014·Application pending·0 cites
- 2857US2014148421A1Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2014·Application pending·0 cites
- 2957US2014011783A1Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2013·Application pending·0 cites
- 3057US2017231994A1Organic compoundsLI PENG·Filed 2017·Application pending·0 cites
- 3156US2020138820A1Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2020·Application pending·0 cites
- 3254US10543194B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2018·Granted Jan 28, 2020·0 cites·5 claims
- 3354US2015197524A1Organic compoundsLI PENG·Filed 2014·Application pending·0 cites
- 3454US2015139903A1Phosphodiesterase 1-targeting tracers and methodsLI PENG·Filed 2014·Application pending·0 cites
- 3553US2014315868A1Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2014·Application pending·0 cites
- 3652US10005789B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2015·Granted Jun 26, 2018·0 cites·17 claims
- 3752US2019144460A1Compounds and methodsINTRA CELLULAR THERAPIES INC·Filed 2018·Application pending·0 cites
- 3852US2016083390A1Organic compoundsLI PENG·Filed 2015·Application pending·0 cites
- 3951US9938284B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2015·Granted Apr 10, 2018·0 cites·30 claims
- 4050US12180210B2CompoundsINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Dec 31, 2024·0 cites·20 claims
- 4142US2015353556A1Organic compoundsLI PENG·Filed 2015·Application pending·0 cites
- 4233US8802675B2Neuroprotective multifunctional compounds and pharmaceutical compositions comprising themYOUDIM MOUSSA B H·Filed 2010·Granted Aug 12, 2014·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Hailin Zheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →